Scholars Central

Short communicationPublished 2014

Exploring Genetically Modified Animals for Development of New Atherosclerosis Treatments in NHLBI

Authors: Boris L Vaisman, Lita Freeman, Alan T Remaley

Molecular and Genetic Medicine

Volume 8 · Issue 2 · Pages 1–3

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Development of New Animal Models of Atherosclerosis Atherosclerosis and complications associated with this pathology, such as coronary artery disease, remains a leading cause of morbidity and mortality in the world [1]. Dyslipidemia is one of the main risk factors leading to development of the atherosclerosis [2,3]. Peripheral (non-hepatic) cells, including arterial and aortic cells, obtain cholesterol from either de novo synthesis or from uptake of plasma lipoproteins. To prevent atherosclerosis, excess cholesterol must be removed from cells. This process takes place through the reverse cholesterol transport pathway [4,5], a process whereby cells efflux excess cholesterol to HDL, which subsequently delivers cholesterol to the liver for excretion into the bile.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalMolecular and Genetic Medicine
  • SubjectGenetics & Molecular Biology
  • BylineArticles whose byline prints “Boris L Vaisman”
  • BylineArticles whose byline prints “Lita Freeman”
  • BylineArticles whose byline prints “Alan T Remaley”